🇺🇸 FDA
Pipeline program

6R-BH4

06/Q1604/114

Phase 2 small_molecule active

Quick answer

6R-BH4 for Coronary Artery Disease is a Phase 2 program (small_molecule) at BIOMARIN PHARMACEUTICAL INC with 1 ClinicalTrials.gov record(s).

Program details

Company
BIOMARIN PHARMACEUTICAL INC
Indication
Coronary Artery Disease
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials